Does Triamterene And Hydrochlorothiazide Interact with Sodium Polystyrene Sulfonate?
CDI records a moderate classification for Triamterene And Hydrochlorothiazide and Sodium Polystyrene Sulfonate. The stored summary is: Exchange resins reduce serum potassium levels by sodium replacement of potassium; fluid retention may occur. The mechanism involves sodium replacement mechanism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Triamterene And Hydrochlorothiazide Class
- Thiazide Diuretic
- Sodium Polystyrene Sulfonate Class
- Potassium Binder
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Sodium replacement mechanism
What To Tell Your Doctor or Pharmacist
If you are taking Triamterene And Hydrochlorothiazide and your doctor is considering prescribing Sodium Polystyrene Sulfonate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider